IZNN yields 20000000.00% · PFE yields 6.13%● Live data
📍 IZNN pulled ahead of the other in Year 1
Combined, IZNN + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IZNN + PFE for your $10,000?
IZON Network, Inc., a golf-centric technology and information-dissemination company, creates a golf technology platform in Canada and the United States. The company connects golfers to advertisers by installing multifunctional Web-enabled interactive tablets in golf cars that operate on and are owned by golf courses across the United States. Its Internet-connected interactive tablets provides a host of services to golfers and golf courses, such as GPS-based hole/course information, aerial views of fairways and green, accurate yardage information to hazards and greens, messaging, online scoring, and beverage cart ordering. The company also offers a portfolio of course management tools designed to enable course managers to improve player pace of play through GPS-based cart tracking and communications, increased merchandise, and concession sales through real-time on-tablet promotions, as well as access to additional revenue streams, such as sale of local advertising. In addition, it provides online marketing services. The company was formerly known as Digital Caddies, Inc. and changed its name to IZON Network, Inc. in September 2017. IZON Network, Inc. was incorporated in 2011 and is headquartered in Scottsdale, Arizona.
Full IZNN Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.